Schinkelshoek, M.S., Fronczek, R., Kooy-Winkelaar, E.M.C., Petersen, J., Reid, H.H., van der Heide, A., Drijfhout, J.W., Rossjohn, Jamie  ORCID: https://orcid.org/0000-0002-2020-7522, Lammers, G.J. and Koning, F.
2019.
H1N1 hemagglutinin-specific HLA-DQ6-restricted CD4+ T cells can be readily detected in narcolepsy type 1 patients and healthy controls.
Journal of Neuroimmunology
332
, pp. 167-175.
10.1016/j.jneuroim.2019.04.009
|
Preview |
PDF
- Published Version
Available under License Creative Commons Attribution No Derivatives. Download (3MB) | Preview |
Abstract
Following the 2009 H1N1 influenza pandemic, an increased risk of narcolepsy type 1 was observed. Homology between an H1N1 hemagglutinin and two hypocretin sequences has been reported. T cell reactivity to these peptides was assessed in 81 narcolepsy type 1 patients and 19 HLA-DQ6-matched healthy controls. HLA-DQ6-restricted H1N1 hemagglutinin-specific T cell responses were detected in 28.4% of patients and 15.8% of controls. Despite structural homology between HLA-DQ6-hypocretin and -H1N1 peptide complexes, T cell cross-reactivity was not detected. These results indicate that it is unlikely that cross-reactivity between H1N1 hemagglutinin and hypocretin peptides presented by HLA-DQ6 is involved in the development of narcolepsy.
| Item Type: | Article |
|---|---|
| Date Type: | Publication |
| Status: | Published |
| Schools: | Schools > Medicine |
| Publisher: | Elsevier |
| ISSN: | 0165-5728 |
| Date of First Compliant Deposit: | 28 May 2019 |
| Date of Acceptance: | 16 April 2019 |
| Last Modified: | 05 May 2023 02:07 |
| URI: | https://orca.cardiff.ac.uk/id/eprint/122911 |
Citation Data
Cited 14 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
 |
Edit Item |
Altmetric
Altmetric